[Form 3] Albemarle Corporation Initial Statement of Beneficial Ownership
Krupa Ander C., General Counsel & Secretary of Albemarle Corporation, reported beneficial ownership of 4,341 common shares, consisting of 1,560 issued shares and 2,781 restricted stock units granted across 2023–2025 with staggered vesting through 2028. She also disclosed 2,676 stock options: 1,608 exercisable 02/27/2028 (exp. 02/26/2035) at $78.97 and 1,068 exercisable 02/22/2027 (exp. 02/21/2034) at $118.18. All holdings and vesting terms are reported on Form 3.
Krupa Ander C., Direttore legale & Segretario societario di Albemarle Corporation, ha dichiarato la proprietà effettiva di 4,341 azioni ordinarie, costituite da 1,560 azioni emesse e 2,781 unità azionarie vincolate (restricted stock units) assegnate nel periodo 2023–2025 con maturazione scaglionata fino al 2028. Ha inoltre comunicato 2,676 opzioni su azioni: 1,608 esercitabili 02/27/2028 (scad. 02/26/2035) a $78.97 e 1,068 esercitabili 02/22/2027 (scad. 02/21/2034) a $118.18. Tutte le partecipazioni e i termini di maturazione sono riportati nel Modulo 3.
Krupa Ander C., Asesora jurídica general & Secretaria de Albemarle Corporation, declaró la titularidad efectiva de 4,341 acciones ordinarias, compuestas por 1,560 acciones emitidas y 2,781 unidades de acciones restringidas otorgadas entre 2023–2025 con vesting escalonado hasta 2028. También divulgó 2,676 opciones sobre acciones: 1,608 ejercitables 02/27/2028 (venc. 02/26/2035) a $78.97 y 1,068 ejercitables 02/22/2027 (venc. 02/21/2034) a $118.18. Todas las participaciones y los términos de vesting se informan en el Formulario 3.
Krupa Ander C., Albemarle Corporation의 법률총괄 & 회사비서로서 4,341 보통주에 대한 실소유권을 신고했습니다. 이는 1,560 발행주와 2023–2025년에 부여되어 단계적으로 베스팅되어 2028까지 완성되는 2,781 제한주식단위(RSU)로 구성됩니다. 또한 2,676 주식매수선택권을 공개했으며, 그 중 1,608주는 02/27/2028(만료 02/26/2035)에 행사 가능(행사가 $78.97), 1,068주는 02/22/2027(만료 02/21/2034)에 행사 가능(행사가 $118.18)합니다. 모든 보유내역과 베스팅 조건은 Form 3에 보고되어 있습니다.
Krupa Ander C., conseillère juridique générale & secrétaire d'Albemarle Corporation, a déclaré la détention effective de 4,341 actions ordinaires, comprenant 1,560 actions émises et 2,781 unités d'actions restreintes attribuées entre 2023–2025 avec un vesting échelonné jusqu'en 2028. Elle a également divulgué 2,676 options d'achat d'actions : 1,608 exerçables le 02/27/2028 (exp. 02/26/2035) à $78.97 et 1,068 exerçables le 02/22/2027 (exp. 02/21/2034) à $118.18. Toutes les positions et conditions de vesting sont déclarées dans le formulaire 3.
Krupa Ander C., General Counsel & Corporate Secretary bei Albemarle Corporation, meldete wirtschaftliches Eigentum an 4,341 Stammaktien, bestehend aus 1,560 ausgegebenen Aktien und 2,781 Restricted Stock Units, gewährt in den Jahren 2023–2025 mit gestaffelter Vesting bis 2028. Sie gab außerdem 2,676 Aktienoptionen an: 1.608 ausübbar am 02/27/2028 (abl. 02/26/2035) zum Preis von $78.97 und 1.068 ausübbar am 02/22/2027 (abl. 02/21/2034) zum Preis von $118.18. Alle Bestände und Vesting-Bedingungen sind im Formular 3 angegeben.
- None.
- None.
Insights
TL;DR: Routine insider Form 3 reports 4,341 shares and 2,676 options; disclosure is informational and not a material corporate event.
The filing provides clear, itemized disclosure of current equity holdings for Krupa Ander C., including the exact split between issued shares and RSUs and full option schedules with exercise prices and expiration dates. This is a standard Section 16 filing that notifies the market of insider holdings rather than indicating a transaction or change in control. The specific numbers and vesting/exercise timelines are useful for monitoring future potential insider exercises or vesting-related sales.
TL;DR: Form 3 documents officer equity exposure and multi-year RSU vesting; relevant for compliance and disclosure records.
The report lists detailed equity compensation components: 2,781 RSUs with discrete vesting dates (2026, 2027, 2028) and 2,676 options with specified exercisable dates, prices, and expirations. For governance and compliance teams, these explicit vesting and option schedules help track insider lockup windows and potential future reportable transactions. The filing is descriptive and aligned with routine reporting obligations.
Krupa Ander C., Direttore legale & Segretario societario di Albemarle Corporation, ha dichiarato la proprietà effettiva di 4,341 azioni ordinarie, costituite da 1,560 azioni emesse e 2,781 unità azionarie vincolate (restricted stock units) assegnate nel periodo 2023–2025 con maturazione scaglionata fino al 2028. Ha inoltre comunicato 2,676 opzioni su azioni: 1,608 esercitabili 02/27/2028 (scad. 02/26/2035) a $78.97 e 1,068 esercitabili 02/22/2027 (scad. 02/21/2034) a $118.18. Tutte le partecipazioni e i termini di maturazione sono riportati nel Modulo 3.
Krupa Ander C., Asesora jurídica general & Secretaria de Albemarle Corporation, declaró la titularidad efectiva de 4,341 acciones ordinarias, compuestas por 1,560 acciones emitidas y 2,781 unidades de acciones restringidas otorgadas entre 2023–2025 con vesting escalonado hasta 2028. También divulgó 2,676 opciones sobre acciones: 1,608 ejercitables 02/27/2028 (venc. 02/26/2035) a $78.97 y 1,068 ejercitables 02/22/2027 (venc. 02/21/2034) a $118.18. Todas las participaciones y los términos de vesting se informan en el Formulario 3.
Krupa Ander C., Albemarle Corporation의 법률총괄 & 회사비서로서 4,341 보통주에 대한 실소유권을 신고했습니다. 이는 1,560 발행주와 2023–2025년에 부여되어 단계적으로 베스팅되어 2028까지 완성되는 2,781 제한주식단위(RSU)로 구성됩니다. 또한 2,676 주식매수선택권을 공개했으며, 그 중 1,608주는 02/27/2028(만료 02/26/2035)에 행사 가능(행사가 $78.97), 1,068주는 02/22/2027(만료 02/21/2034)에 행사 가능(행사가 $118.18)합니다. 모든 보유내역과 베스팅 조건은 Form 3에 보고되어 있습니다.
Krupa Ander C., conseillère juridique générale & secrétaire d'Albemarle Corporation, a déclaré la détention effective de 4,341 actions ordinaires, comprenant 1,560 actions émises et 2,781 unités d'actions restreintes attribuées entre 2023–2025 avec un vesting échelonné jusqu'en 2028. Elle a également divulgué 2,676 options d'achat d'actions : 1,608 exerçables le 02/27/2028 (exp. 02/26/2035) à $78.97 et 1,068 exerçables le 02/22/2027 (exp. 02/21/2034) à $118.18. Toutes les positions et conditions de vesting sont déclarées dans le formulaire 3.
Krupa Ander C., General Counsel & Corporate Secretary bei Albemarle Corporation, meldete wirtschaftliches Eigentum an 4,341 Stammaktien, bestehend aus 1,560 ausgegebenen Aktien und 2,781 Restricted Stock Units, gewährt in den Jahren 2023–2025 mit gestaffelter Vesting bis 2028. Sie gab außerdem 2,676 Aktienoptionen an: 1.608 ausübbar am 02/27/2028 (abl. 02/26/2035) zum Preis von $78.97 und 1.068 ausübbar am 02/22/2027 (abl. 02/21/2034) zum Preis von $118.18. Alle Bestände und Vesting-Bedingungen sind im Formular 3 angegeben.